Diazepam for Anxiety
Diazepam can be used for short-term management of anxiety disorders, but it should be reserved for acute situations or as a bridge therapy, not as first-line treatment, with dosing of 2-10 mg given 2-4 times daily for a maximum duration of 4 weeks to minimize dependence and withdrawal risks 1.
Treatment Hierarchy and When to Use Diazepam
The evidence strongly favors SSRIs (selective serotonin reuptake inhibitors) as first-line pharmacotherapy for anxiety disorders 2, 3. Benzodiazepines like diazepam should be considered in specific clinical scenarios:
- Acute stress reactions requiring rapid symptom control
- Initial bridging therapy while waiting for SSRIs to take effect (which typically requires 3-6 months for maximal benefit) 4
- Episodic anxiety or fluctuations in generalized anxiety
- Acute alcohol withdrawal (10 mg 3-4 times daily in first 24 hours, then 5 mg 3-4 times daily) 1
Dosing Protocol
For anxiety management 1:
- Start with 2-10 mg, 2-4 times daily depending on symptom severity
- Elderly or debilitated patients: 2-2.5 mg, 1-2 times daily initially
- Optimal therapeutic dose averages 15-18 mg/day 5
- Maximum effective dose appears to be 12-18 mg/day with treatment duration of 2+ weeks 6
Critical caveat: Doses of 6 mg/day show no significant difference from placebo 6, so inadequate dosing is a common pitfall.
Duration Limits and Withdrawal Risk
The duration of treatment is the single most important factor determining withdrawal reactions 7:
- Less than 8 weeks continuous use: 5% withdrawal incidence
- 8 months or more continuous use: 43% withdrawal incidence
- Recommended maximum: 4 weeks for most patients 1, 8
- Optimal duration: Most improvement occurs by 4 weeks; continuing beyond this should only be for patients maximally improved at 4 weeks 4
The FDA label explicitly states that effectiveness beyond 4 months has not been systematically assessed 1.
Discontinuation Protocol
Never abruptly stop diazepam 1. Use gradual taper to reduce withdrawal risk:
- If withdrawal reactions develop, pause the taper or increase back to previous dose
- Then decrease more slowly
- Withdrawal reactions are manageable but can cause considerable distress 7
Comparative Efficacy
Diazepam demonstrates significant efficacy over placebo (relative risk 1.35, number needed to treat = 9) 6. In head-to-head comparison with alprazolam, diazepam showed superior reduction of anxiety and depressive symptoms, with more readily achieved adequate anxiety control 5. However, benzodiazepines vary in efficacy across anxiety disorders—they are superior in social anxiety disorder but may be less effective than SSRIs in generalized anxiety disorder, and are not effective in PTSD 9.
Safety Warnings
The FDA black box warnings 1 mandate awareness of:
- Concomitant opioid use: Profound sedation, respiratory depression, coma, death—reserve only when no alternatives exist
- Abuse and misuse potential: Assess risk before and throughout treatment
- Physical dependence: Increases with duration and dose
Why Not First-Line?
International guidelines consistently recommend SSRIs over benzodiazepines 3. The Japanese guideline lists benzodiazepines (alprazolam, bromazepam, clonazepam) only as second-line agents. The pediatric guideline 2 emphasizes combination CBT plus SSRI as preferred treatment, with no mention of benzodiazepines as appropriate therapy for children and adolescents with anxiety disorders.
Common adverse effects: Psychomotor impairment (especially elderly), paradoxical excitement, tolerance, and dependence with long-term use 8.